top
Search terms
Results 1 - 8 of 8 - ordered by :
Ehjournal

In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. Methods and results We ...

European Heart Journal, Hohnloser, Stefan H., Crijns, Harry J.G.M., van Eickels, Martin, Gaudin, Christophe, Page, Richard L., Torp-Pedersen, Christian, Connolly, Stuart J.

Date : 01/07/2010
Ehjournal

Abstract Aims The aim of this study was to evaluate the effects of apixaban, a novel oral factor Xa inhibitor, on the need for cardiovascular hospitalization. Methods and results Our analysis is ...

European Heart Journal, Hohnloser, Stefan H., Shestakovska, Olga, Eikelboom, John, Franzosi, Maria Grazia, Tan, Ru San, Zhu, Jun, Yusuf, Salim, Connolly, Stuart J.

Date : 14/09/2013 Item size : 209869 bytes
Ehjournal

Conclusion In a large population of non-anticoagulated AF patients, pattern of AF was a strong independent predictor of stroke risk and may be helpful to assess the risk/benefit for anticoagulant ...

European Heart Journal, Vanassche, Thomas, Lauw, Mandy N., Eikelboom, John W., Healey, Jeff S., Hart, Robert G., Alings, Marco, Avezum, Alvaro, Díaz, Rafael, Hohnloser, Stefan H., Lewis, Basil S., ...

Date : 01/02/2015 Item size : 328635 bytes
Ehjournal

Whereas it is well appreciated that stroke risk in end-stage renal disease is elevated,4 the issue of AF-associated thrombo-embolic risk is more controversial in patients with CKD not on renal ...

European Heart Journal, Hohnloser, Stefan H., Connolly, Stuart J.

Date : 01/10/2011
Ehjournal

Methods and results Patients with AF and more than one risk factor for stroke were randomized to one of three blinded doses of betrixaban (40, 60, or 80 mg once daily) or unblinded warfarin, adjusted ...

European Heart Journal, Connolly, Stuart J., Eikelboom, John, Dorian, Paul, Hohnloser, Stefan H., Gretler, Daniel D., Sinha, Uma, Ezekowitz, Michael D.

Date : 21/05/2013
Ehjournal

[...]it has been shown that the risk of bleeding associated with warfarin therapy is particularly high in patients with CKD.7 Hence, there is a formidable clinical dilemma in AF patients who are ...

European Heart Journal, Hohnloser, Stefan H., Connolly, Stuart J.

Date : 01/10/2011 Item size : 149538 bytes
Ehjournal

In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. Methods and results We ...

European Heart Journal, Hohnloser, Stefan H., Crijns, Harry J.G.M., van Eickels, Martin, Gaudin, Christophe, Page, Richard L., Torp-Pedersen, Christian, Connolly, Stuart J.

Date : 01/07/2010
Ehjournal

Conclusion In a large population of non-anticoagulated AF patients, pattern of AF was a strong independent predictor of stroke risk and may be helpful to assess the risk/benefit for anticoagulant ...

European Heart Journal, Vanassche, Thomas, Lauw, Mandy N., Eikelboom, John W., Healey, Jeff S., Hart, Robert G., Alings, Marco, Avezum, Alvaro, Díaz, Rafael, Hohnloser, Stefan H., Lewis, Basil S., ...

Date : 01/02/2015 Item size : 378706 bytes